Protagonist Therapeutics logo
Protagonist Therapeutics PTGX
$ 101.92 -0.94%

Annual report 2025
added 02-25-2026

report update icon

Protagonist Therapeutics Depreciation & Amortization 2011-2026 | PTGX

Annual Depreciation & Amortization Protagonist Therapeutics

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.28 M 826 K 977 K 1.03 M 813 K 948 K 732 K 527 K 406 K 317 K 247 K 258 K - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
1.28 M 247 K 697 K

Quarterly Depreciation & Amortization Protagonist Therapeutics

2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - 239 K - - - 236 K - - - 248 K - 778 K - 249 K - 578 K - 180 K - 601 K 419 K 217 K - 501 K 306 K 130 K - 399 K 248 K 78 K - 289 K 181 K 88 K - 242 K 159 K 73 K - 160 K 111 K - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
778 K 73 K 280 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer Depreciation & Amortization Price % 24h Market Cap Country
I-Mab I-Mab
IMAB
23.9 M - - $ 866 M chinaChina
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
8.3 M $ 1.34 -3.6 % $ 357 M britainBritain
Acorda Therapeutics Acorda Therapeutics
ACOR
31.7 M - -24.86 % $ 820 K usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
2.99 M $ 20.13 -1.13 % $ 2.81 B franceFrance
Advaxis Advaxis
ADXS
369 K - -9.65 % $ 45.9 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
3.65 M - - $ 86.2 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
5.38 M $ 2.57 -3.57 % $ 16.1 M usaUSA
Equillium Equillium
EQ
116 K $ 2.04 1.24 % $ 117 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
58 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
100 K - -10.17 % $ 12.2 K usaUSA
Fate Therapeutics Fate Therapeutics
FATE
12.9 M $ 1.13 -5.04 % $ 134 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
744 K - - $ 1.01 B usaUSA
Forte Biosciences Forte Biosciences
FBRX
64 K $ 26.57 0.49 % $ 344 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.51 M - - $ 26.5 M usaUSA
Foghorn Therapeutics Foghorn Therapeutics
FHTX
3.33 M $ 4.74 -2.87 % $ 299 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
105 K - 1.93 % $ 17.4 M usaUSA
Amicus Therapeutics Amicus Therapeutics
FOLD
7.46 M $ 14.46 0.03 % $ 4.46 B usaUSA
Aptose Biosciences Aptose Biosciences
APTO
22 K - -45.71 % $ 1.2 M canadaCanada
Fulcrum Therapeutics Fulcrum Therapeutics
FULC
1.39 M $ 7.55 -3.58 % $ 478 K usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
1 K $ 2.25 -12.3 % $ 144 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
18 K - - $ 3.67 B usaUSA
Gilead Sciences Gilead Sciences
GILD
370 M $ 138.19 -1.38 % $ 172 B usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
1.3 M $ 1.61 -3.59 % $ 189 M usaUSA
Akari Therapeutics, Plc Akari Therapeutics, Plc
AKTX
14 K $ 3.5 -1.13 % $ 236 B britainBritain
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
42 K $ 0.54 4.26 % $ 503 K israelIsrael
Allakos Allakos
ALLK
6.14 M - - $ 28.6 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
363 K - 3.16 % $ 1.9 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
55.7 M $ 314.44 -4.81 % $ 41.2 B usaUSA
Gossamer Bio Gossamer Bio
GOSS
24 K $ 0.32 -7.11 % $ 73.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
597 K - - $ 2.17 B usaUSA
GT Biopharma GT Biopharma
GTBP
4 K $ 0.42 -6.49 % $ 2.32 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
1 K - 10.36 % $ 9.8 M usaUSA
AlloVir AlloVir
ALVR
13 K - 4.14 % $ 49.1 M usaUSA
Halozyme Therapeutics Halozyme Therapeutics
HALO
11.4 M $ 63.51 0.68 % $ 7.61 B usaUSA